| Code | 5910D | ||||||||||
| MA number | 16/0262/20-S | ||||||||||
| Product Form: | tbl flm 20x1x2,5 mg (blis.PVC/PE/PVDC/Al-jednotliv.dáv.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | TEVA Pharmaceuticals Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 30.11.2020 |
| Dokument: |
Apixaban_Príručka pre lekára.pdf
|
| SPC: |
SPC_Apixaban Teva 2,5 mg_06.2025.pdf
|
| PIL: |
PIL_Apixaban Teva 2,5 mg_06.2025.pdf
|
| Safety feature | Yes |
| Data update: | 07.07.2025 |
